Citigroup
CNTB

Citigroup’s Connect Biopharma Holdings CNTB Stock Holding History

Citigroup’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Buy
6,986
+6,985
+698,500% +$16.9K ﹤0.01% 5179
2026
Q1 		$3 Buy
+1
New +$3 ﹤0.01% 5806
2025
Q4 		– Sell
-4,214
Closed -$6.24K – 6125
2025
Q3 		$6.24K Buy
+4,214
New +$7.46K ﹤0.01% 5173
2023
Q1 		– Sell
-139,196
Closed -$121K – 5553
2022
Q4 		$121K Sell
139,196
-75,517
-35% -$62.2K ﹤0.01% 3951
2022
Q3 		$277K Sell
214,713
-160,654
-43% -$193K ﹤0.01% 3606
2022
Q2 		$327K Buy
375,367
+374,314
+35,547% +$551K ﹤0.01% 3548
2022
Q1 		$3K Sell
1,053
-1,910
-64% -$8.06K ﹤0.01% 5949
2021
Q4 		$15K Buy
2,963
+1,965
+197% +$21.8K ﹤0.01% 5466
2021
Q3 		$24K Sell
998
-415
-29% -$9.39K ﹤0.01% 5150
2021
Q2 		$28K Buy
+1,413
New +$23.6K ﹤0.01% 5117

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Citigroup's CNTB Position: Q2 2026 in Review

Citigroup increased its Connect Biopharma Holdings (CNTB) stake by 698,500% in Q2 2026, buying an estimated $16.9K and bringing the position to 6,986 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5179.

Citigroup first reported a position in CNTB in Q2 2021 and has held it in 10 quarters since. The position peaked at $327K in Q2 2022. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Citigroup held 6,986 shares of Connect Biopharma Holdings worth $16.6K as of Q2 2026.
  • Citigroup bought 6,985 Connect Biopharma Holdings shares in Q2 2026, an estimated $16.9K.
  • Connect Biopharma Holdings made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5179 holding.
  • Citigroup first reported a position in Connect Biopharma Holdings in Q2 2021 and has held it in 10 quarters since.
  • Citigroup's Connect Biopharma Holdings position peaked at $327K in Q2 2022.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.